• $70.2M
    Market Cap
  • -57.61%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
58.4M
+9.24%
53.5M
+26.87%
42.2M
+19.25%
35.4M
+2.61%
Cost of Revenue
31.3M
+13.28%
27.6M
+31.28%
21.1M
+36.71%
15.4M
-7.36%
Gross Profit
27.1M
+4.92%
25.9M
+22.48%
21.1M
+5.77%
20.0M
+11.90%
Sales and Marketing Expense
45.2M
+70.48%
26.5M
+1.49%
26.1M
-3.94%
27.2M
+13.74%
Research and Development Expense
-5.6M
+5.50%
-5.3M
-13.19%
-6.1M
-48.04%
-11.8M
-4.40%
Depreciation and Amortization Expense
921,000
-5.05%
970,000
-11.58%
1.1M
-4.44%
1.1M
-7.42%
Total Operating Expenses
96.9M
+53.73%
63.0M
+141.39%
26.1M
-3.94%
27.2M
+13.74%
Operating Profit
-24.6M
+130.45%
-10.7M
-12.79%
-12.2M
-39.39%
-20.2M
+2.67%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
636,000
-3.64%
660,000
-5.44%
698,000
+165.40%
263,000
+415.69%
Income before Taxes
-24.6M
+130.45%
-10.7M
-12.79%
-12.2M
-39.39%
-20.2M
+2.94%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-34.3M
+9.16%
-31.4M
+118.34%
-14.4M
-27.77%
-19.9M
+1.60%
Net Income from Continuing Operations Applicable to Common
-34.3M
+9.16%
-31.4M
+118.34%
-14.4M
-27.77%
-19.9M
+1.60%
Basic EPS and Net Income
-2.87
+5.13%
-2.73
+108.40%
-1.31
-33.16%
-1.96
-6.22%
Diluted EPS and Net Income
-2.87
+5.13%
-2.73
+108.40%
-1.31
-33.16%
-1.96
-6.22%
Basic Weighted Average Shares
12.0M
+3.82%
11.5M
+4.99%
11.0M
+7.99%
10.2M
+8.37%
Diluted Weighted Average Shares
12.0M
+3.82%
11.5M
+4.99%
11.0M
+7.99%
10.2M
+8.37%
Balance Sheet
Cash and Cash Equivalents
13.0M
-20.22%
16.3M
-21.13%
20.6M
+40.53%
14.7M
-53.62%
Short-Term Investments
5.0M
-19.19%
6.2M
+79.84%
3.4M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
18.0M
-19.94%
22.5M
-6.69%
24.1M
+63.99%
14.7M
-53.62%
Total Current Assets
46.8M
+11.42%
42.0M
-9.61%
46.4M
+37.75%
33.7M
-24.76%
Accumulated Depreciation
2.2M
-6.37%
2.4M
+0.17%
2.4M
+6.34%
2.2M
+15.12%
Property and Plant and Equipment and Net
505,000
-23.95%
664,000
-2.21%
679,000
+20.60%
563,000
-25.53%
Total Long-Term Assets
2.7M
+5.05%
2.6M
+18.49%
2.2M
-17.80%
2.7M
-16.49%
Total Assets
71.4M
+7.74%
66.3M
-4.73%
69.6M
+24.61%
55.8M
-15.98%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
40.6M
+170.44%
15.0M
+28.98%
11.6M
+1.85%
11.4M
+31.06%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
909,000
+29.49%
702,000
+23.16%
570,000
+241.32%
167,000
+142.03%
Total Liabilities
83.7M
+75.58%
47.7M
+112.64%
22.4M
+61.68%
13.9M
+19.63%
Retained Earnings
-177.6M
+23.92%
-143.3M
+28.07%
-111.9M
+14.75%
-97.5M
+25.66%
Total Stockholders Equity
-26.0M
-635.15%
4.9M
-85.46%
33.4M
-20.38%
42.0M
-23.50%
Total Shares Outstanding
12.0M
+2.91%
11.7M
+2.89%
11.3M
+2.11%
11.1M
+0.94%
Cash Flow
Cash from Operating Activities
-14.8M
+551.91%
-2.3M
-76.45%
-9.7M
-34.98%
-14.9M
+65.64%
Capital Expenditures
83,000
-46.79%
156,000
-33.90%
236,000
+105.22%
115,000
-67.51%
Cash from Investing Activities
1.3M
+159.42%
-2.2M
-48.00%
-4.2M
+3,513.91%
-115,000
-67.51%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.3M
+13,051.28%
78,000
-99.61%
19.8M
+1,092.07%
-2.0M
-651.80%
Financials Ratio
Gross Margin
46.41%
-3.95%
48.33%
-3.46%
50.06%
-11.30%
56.44%
+9.05%
Operating Margin
-42.06%
+110.97%
-19.94%
-31.26%
-29.00%
-49.17%
-57.06%
+0.06%
Return on Assets
-49.78%
+7.70%
-46.22%
+101.54%
-22.93%
-29.57%
-32.56%
+20.93%
Return on Equity
324.05%
+297.56%
-164.03%
+330.02%
-38.14%
-7.23%
-41.12%
+28.06%
Revenue Growth
9.24%
-65.63%
26.87%
+39.60%
19.25%
+637.81%
2.61%
-91.48%
Current Ratio
1.15
-58.80%
2.80
-29.92%
3.99
+35.25%
2.95
-42.60%
Cash Ratio
0.32
-70.50%
1.08
-38.85%
1.77
+37.98%
1.28
-64.61%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow